Inspire Medical Systems Total Liabilities 2017-2024 | INSP

Inspire Medical Systems total liabilities from 2017 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Inspire Medical Systems total liabilities for the quarter ending September 30, 2024 were $0.100B, a 4.53% increase year-over-year.
  • Inspire Medical Systems total liabilities for 2023 were $0.104B, a 51.44% increase from 2022.
  • Inspire Medical Systems total liabilities for 2022 were $0.069B, a 4.29% increase from 2021.
  • Inspire Medical Systems total liabilities for 2021 were $0.066B, a 28.37% increase from 2020.
Inspire Medical Systems Annual Total Liabilities
(Millions of US $)
2023 $104
2022 $69
2021 $66
2020 $51
2019 $41
2018 $36
2017 $24
2016 $0
Inspire Medical Systems Quarterly Total Liabilities
(Millions of US $)
2024-09-30 $100
2024-06-30 $90
2024-03-31 $97
2023-12-31 $104
2023-09-30 $95
2023-06-30 $89
2023-03-31 $67
2022-12-31 $69
2022-09-30 $57
2022-06-30 $65
2022-03-31 $65
2021-12-31 $66
2021-09-30 $59
2021-06-30 $52
2021-03-31 $50
2020-12-31 $51
2020-09-30 $43
2020-06-30 $38
2020-03-31 $38
2019-12-31 $41
2019-09-30 $37
2019-06-30 $33
2019-03-31 $32
2018-12-31 $36
2018-09-30 $32
2018-06-30 $31
2018-03-31 $33
2017-12-31 $24
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.669B $0.625B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Hims & Hers Health (HIMS) United States $5.506B 140.00
Tempus AI (TEM) United States $5.393B 0.00
IRhythm Technologies (IRTC) United States $2.799B 0.00
Enovis (ENOV) United States $2.475B 16.78
Privia Health (PRVA) United States $2.357B 196.40
Azenta (AZTA) United States $2.286B 122.05
Omnicell (OMCL) United States $2.053B 67.15
10x Genomics (TXG) United States $1.718B 0.00
Clover Health Investments (CLOV) United States $1.568B 0.00
Schrodinger (SDGR) United States $1.486B 0.00
Phreesia (PHR) United States $1.464B 0.00
Butterfly Network (BFLY) United States $0.846B 0.00
Standard BioTools (LAB) United States $0.651B 0.00
Fulgent Genetics (FLGT) United States $0.563B 0.00
Talkspace (TALK) United States $0.529B 0.00
Definitive Healthcare (DH) United States $0.476B 82.40
Health Catalyst (HCAT) United States $0.446B 0.00
TruBridge (TBRG) United States $0.297B 86.52
Pulmonx (LUNG) United States $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
EUDA Health Holdings (EUDA) Singapore $0.114B 0.00
American Well (AMWL) United States $0.108B 0.00
P3 Health Partners (PIII) United States $0.090B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
CareCloud (CCLD) United States $0.062B 0.00
Outset Medical (OM) United States $0.061B 0.00
111 (YI) China $0.054B 0.00
Zepp Health (ZEPP) China $0.043B 0.00
Zhongchao (ZCMD) China $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.041B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Precipio (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00